Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma

Archives of Ophthalmology

Volumn 117, Issue 7, 1999, Pages 917-924

  Tezel, Gülgün ^a   Edward, Deepak P ^b   Wax, Martin B ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE;

ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SPECIFICITY; GLAUCOMA; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOLECULAR RECOGNITION; OPTIC NERVE LESION; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 0032798811     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.117.7.917     Document Type: Article

References (42)

1. Quigley HA, Addicks W, Green R, Maumenee AE. Optic nerve damage in human glaucoma, II: the site of injury and susceptibility of damage. Arch Ophthalmol. 1981;99:635-649.
2. Quigley HA, Hohmam RM, Addicks EM, Massof RW, Green WR. Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. Am J Ophthalmol. 1983;95:673-691.
3. Tezel G, Kass MA, Kolker AE, Wax MB. Comparative analysis of optic disc parameters in normal pressure glaucoma, primary open-angle glaucoma and ocular hypertension. Ophthalmology. 1996;103:2105-2113.
4. Wax MB, Tezel G, Edward PD. Clinical and histopathological findings of a patient with normal-pressure glaucoma. Arch Ophthalmol. 1998;116:993-1001.
5. Quigley HA, Green WR. The histology of human glaucoma cupping and optic nerve damage: clinicopathologic correlation in 21 eyes. Ophthalmology. 1979; 86:1803-1827.
6. Caparas VL, Cintron C, Hernandez-Neufeld MR. Immunohistochemistry of proteoglycans in human lamina cribrosa. Am J Ophthalmol. 1991;112:489-495.
7. Sawaguchi S, Yue BYJT, Iwata K, Fukuchi T, Kaiya T. Sulfated proteoglycans in the human lamina cribrosa. Invest Ophthalmol Vis Sci. 1992;33:2388-2398.
8. Ruoslahti E. Structure and biology of proteoglycans. Annu Rev Cell Biol. 1988; 4:229-255.
9. Fukuchi T, Sawaguchi S, Yue BYJT, Iwata K, Hara H, Kaiya T. Sulfaled proteoglycans in the lamina cribrosa of normal monkey eyes and monkey eyes with laser-induced glaucoma. Exp Eye Res. 1994;58:231-243.
10. Faaber P, Capel PJA, Rijke GPM, Vierwinden G, van de Putte LBA, Koene RAP. Cross-reactivity of anti-DNA antibodies with proteoglycans. Clin Exp Immunol. 1984;55:502-508.
11. Faaber P, Rijke TPM, van de Putte LB, Capel PJA, Berden JHM. Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. J Clin Invest. 1986;77:1824-1830.
12. Hansen CH, Otto E, Kuhlemann K, Forster G, Kahaly GJ. Glycosaminoglycans in autoimmunity. Clin Exp Rheumatol. 1996;14:S59-S67.
13. Cartwright MJ, Grajewski AL, Friedberg ML, Anderson DR, Richards DW. Immune-related disease and normal-tension glaucoma. Arch Ophthalmol. 1992;110: 500-502.
14. Wax MB, Barrett DA, Pestronk A. Increased incidence of paraproteinemia and autoantibodies in patients with normal pressure glaucoma. Am J Ophthalmol. 1994;117:561-568.
15. Romano C, Barrett DA, Li Z, Pestronk A, Wax MB. Anti-rhodopsin antibodies in sera from patients with normal-pressure glaucoma. Invest Ophthalmol Vis Sci. 1995;36:1968-1975.
16. Wax MB, Tezel G, Saito I, et al. Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma. Am J Ophthalmol. 1998; 125:145-157.
17. Tezel G, Seigel GM, Wax MB. Autoantibodies to small heat shock proteins in glaucoma. Invest Ophthalmol Vis Sci. 1998;39:2277-2287.
18. Hjelmeland LM. Solubilization of native membrane proteins. In: Deutscher MP, ed. Methods of Enzymology: Guide to Protein Purification. Vol 182. San Diego, Calif: Academic Press; 1990:253-264.
19. Couchman JR, Caterson B, Christner JE, Baker JR. Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissues. Nature. 1984;307:650-652.
20. Caterson B, Christner JE, Baker JR, Couchman JR. Production and characterization of monoclonal antibodies directed against connective tissue proteoglycans. Fed Proc. 1985;44:386-393.
21. Wright TN, Kinsella MG, Qwarnstrom EE. The role of proteoglycans in cell adhesion, migration and proliferation. Curr Opin Cell Biol. 1992;4:793-801.
22. Gong H, Ye W, Freddo TF, Hernandez MR. Hyaluronic acid in the normal and glaucomatous optic nerve. Exp Eye Res. 1997;64:587-595.
23. Muir H. Proteoglycans as organizers of the intercellular matrix. Biochem Soc Trans. 1983;11:613-622.
24. Bettelheim FA, Ehrlich SH. Water vapor sorption of mucopolysaccharides. J Physiol Chem. 1963;67:1948-1953.
25. Bettelheim FA, Plessy B. The hydration of proteoglycans of bovine cornea. Biochim Biophys Acta. 1975;381:203-214.
26. Snow DM, Watanabe M, Letourneau PC, Silver J. A chondroitin sulfate proteoglycan may influence the direction of retinal ganglion cell outgrowth. Development. 1991;113:1473-1485.
27. Snow DM, Letourneau PC. Neurite outgrowth on a step gradient of chondroitin sulfate proteoglycan. J Neurobiol. 1992;23:322-336.
28. Morrison JC, Jerden JA, L'Hernault NL, Quigley HA. The extracellular matrix composition of the monkey optic nerve head. Invest Ophthalmol Vis Sci. 1988;29: 1141-1150.
29. Goldbaum MH, Jeng S, Longemann R, Weinreb RN. The extracellular matrix of the human optic nerve head. Arch Ophthalmol. 1989;107:1225-1231.
30. Farquhar MG. The glomerular basement membrane: a selective macromolecular filter. In: Hay ED, ed. Cell Biology of Extracellular Matrix. New York, NY: Plenum Press; 1981:335-378.
31. Carbonetto S. The extracellular matrix of the nervous systems. Trends Neurosci. 1984;7:382-387.
32. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 1991;64:867-869.
33. Sawaguchi S, Yue BY, Fukuchi T, Iwata K, Kaiya T. Age-related changes of sulfated proteoglycans in the human lamina cribrosa. Curr Eye Res. 1993;12: 685-692.
34. Morrison JC, Rask P, Johnson EC, Deppmeier L. Chondroitin sulfate proteoglycan distribution in the primate optic nerve head. Invest Ophthalmol Vis Sci. 1994; 35:838-845.
35. Johnson EC, Morrison JC, Farrell S, Deppmeier L, Moore CG, McGinty MR. The effect of chronically elevated intraocular pressure on the rat optic nerve head extracellular matrix. Exp Eye Res. 1996;62:663-673.
36. Fugassa E, Taningher M, Gallo G, Orunesu M. Fibrillation of α-elastin induced by proteoglycan. Experientia. 1975;31:523-524.
37. Velebny V, Ledvina M, Lankasova V. Interaction of a tropoelastin model with connective tissue components. Connect Tissue Res. 1981;9:63-68.
38. Bartholomew JS, Anderson JC. Investigation of relationships between collagens, elastin and proteoglycans in bovine thoracic aorta by immunofluorescence techniques. Histochemistry. 1983;15:1177-1190.
39. Contri MB, Fornieri C, Ronchetti IP. Elastin-proteoglycans association revealed by cytochemical methods. Connect Tissue Res. 1985;13:237-249.
40. Quigley HA, Brown A, Dorman-Pease ME. Alterations in elastin of the optic nerve head in human and experimental glaucoma. Br J Ophthalmol. 1991;75:552-557.
41. Kahaly G, Stover C, Otto E, Beyer J, Schuler M. Glycosaminoglycans in thyroid-associated ophthalmopathy. Autoimmunity. 1992;13:81-88.
42. Kahaly G, Hansen CE, Stover C, Beyer J, Otto E. Glycosaminoglycan antibodies in endocrine ophthalmopathy. Horm Metab Res. 1993;25:637-639.